Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 5 of 5

Publication Record

Connections

The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapy.
Koethe JR, Grome H, Jenkins CA, Kalams SA, Sterling TR
(2016) AIDS 30: 83-91
MeSH Terms: Adult, Alkynes, Anti-Retroviral Agents, Benzoxazines, Cardiovascular Diseases, Cohort Studies, Cyclopropanes, Emtricitabine, Female, HIV Infections, Humans, Male, Metabolic Diseases, Middle Aged, Obesity, Risk Assessment, Tenofovir
Added February 17, 2016
0 Communities
1 Members
0 Resources
17 MeSH Terms
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.
Lennox JL, Landovitz RJ, Ribaudo HJ, Ofotokun I, Na LH, Godfrey C, Kuritzkes DR, Sagar M, Brown TT, Cohn SE, McComsey GA, Aweeka F, Fichtenbaum CJ, Presti RM, Koletar SL, Haas DW, Patterson KB, Benson CA, Baugh BP, Leavitt RY, Rooney JF, Seekins D, Currier JS, ACTG A5257 Team
(2014) Ann Intern Med 161: 461-71
MeSH Terms: Adenine, Adult, Atazanavir Sulfate, Darunavir, Deoxycytidine, Drug Combinations, Drug Therapy, Combination, Emtricitabine, Female, HIV Infections, HIV Protease Inhibitors, HIV-1, Humans, Male, Oligopeptides, Organophosphonates, Pyridines, RNA, Viral, Reverse Transcriptase Inhibitors, Sulfonamides, Tenofovir, Therapeutic Equivalency, Viral Load
Added March 13, 2015
0 Communities
1 Members
0 Resources
23 MeSH Terms
Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002-2009.
Abgrall S, Ingle SM, May MT, Costagliola D, Mercie P, Cavassini M, Reekie J, Samji H, Gill MJ, Crane HM, Tate J, Sterling TR, Antinori A, Reiss P, Saag MS, Mugavero MJ, Phillips A, Manzardo C, Wasmuth JC, Stephan C, Guest JL, Gomez Sirvent JL, Sterne JA, Antiretroviral Therapy Cohort Collaboration (ART-CC)
(2013) AIDS 27: 803-13
MeSH Terms: Adenine, Alkynes, Anti-HIV Agents, Antiretroviral Therapy, Highly Active, Benzoxazines, Cohort Studies, Cyclopropanes, Deoxycytidine, Dideoxynucleosides, Drug Combinations, Emtricitabine, Europe, HIV Infections, HIV Protease Inhibitors, HIV Seropositivity, HIV-1, Humans, Lamivudine, Lopinavir, Nevirapine, Organophosphonates, Reverse Transcriptase Inhibitors, Risk Factors, Tenofovir, Time Factors, United States
Added February 17, 2016
0 Communities
1 Members
0 Resources
26 MeSH Terms
A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B.
Lim SG, Ng TM, Kung N, Krastev Z, Volfova M, Husa P, Lee SS, Chan S, Shiffman ML, Washington MK, Rigney A, Anderson J, Mondou E, Snow A, Sorbel J, Guan R, Rousseau F, Emtricitabine FTCB-301 Study Group
(2006) Arch Intern Med 166: 49-56
MeSH Terms: Adult, Aged, Alanine Transaminase, Antiviral Agents, Biopsy, Needle, DNA, Viral, Deoxycytidine, Double-Blind Method, Emtricitabine, Female, Genotype, Hepatitis B Antibodies, Hepatitis B virus, Hepatitis B, Chronic, Humans, Liver, Male, Middle Aged, Placebo Effect, Treatment Outcome, Viral Load
Added March 5, 2014
0 Communities
1 Members
0 Resources
21 MeSH Terms
A randomized study of emtricitabine and lamivudine in stably suppressed patients with HIV.
Benson CA, van der Horst C, Lamarca A, Haas DW, McDonald CK, Steinhart CR, Rublein J, Quinn JB, Mondou E, Rousseau F, FTC-303/350 Writing Group
(2004) AIDS 18: 2269-76
MeSH Terms: Adult, Anti-HIV Agents, CD4 Lymphocyte Count, Deoxycytidine, Emtricitabine, Female, Genotype, HIV Infections, HIV-1, Humans, Lamivudine, Male, RNA, Viral, Reverse Transcriptase Inhibitors, Treatment Outcome, Viral Load
Added March 13, 2015
0 Communities
1 Members
0 Resources
16 MeSH Terms